Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT06293898

1 development in the corpus

NCT06293898

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 10, 2026 · PHASE 1 TRIAL

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

ClinicalTrials.gov

This is a Phase 1 open-label trial still recruiting, with no results posted; it represents early-stage evaluation of a novel therapeutic agent.

PreliminarySystImmune NCT06293898 BL-M07D1

Reported

PhasePHASE 1

Planned enrollment280

Study durationapproximately 24 months

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support